Glanzeng's holding of the number one heavy stock, El Ophthalmology, has been reduced for two consecutive reporting periods.

FAP, June 1 / PRNewswire-FirstCall-Asianet /-- due to share buybacks, Ayre Ophthalmology today disclosed its shareholders' shareholdings as of May 26. Glenn's China Europe Medical Health continues to rank as the fourth largest tradable shareholder and the largest public offering shareholder, holding a total of 197.9911 million shares as of May 26, an increase of 4.7328 million shares compared with the end of the first quarter. Prior to this, Glenn's CEIBS Healthcare has reduced its holdings in El Ophthalmology for two consecutive reporting periods, but Wind data show that as of the first quarter of this year, the stock is still its largest heavy stock, accounting for 9.51% of the total net asset value of all Glen's products under management. If calculated according to the total management scale of 84.44 billion yuan by the end of the first quarter, the total position market value exceeds 8 billion yuan. Ayre ophthalmology shares have fluctuated downwards since the second quarter, closing down 12.36% as of today, and just hit a new low for the year on May 30.